miRNA replacement | GenomeWeb

miRNA replacement

Despite the delay, Mirna has gained some traction in its efforts to form an industry partnership, having inked technology-evaluation deals with two pharmaceutical companies.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.